Back

Hot Pursuit

JB Chemicals & Pharmaceuticals has announced that its API (Active Pharmaceutical Ingredient) manufacturing facility (D9) in Panoli, Gujarat, successfully cleared a US Food and Drug Administration (USFDA) inspection without any observations.

JB Chemicals Panoli facility clears USFDA inspection with zero observations

15-Mar-2025, 11:58
The inspection, conducted from 10 March to 13 March 2025, concluded with no Form 483 issued.

'The company said that it remains committed to producing quality products, embedding a quality culture across the organization, and continuously investing in systems, processes & training of its employees so that it can maintain the highest standards of quality and compliance for all its markets.' JB Chemicals stated.

JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates.

The company's consolidated net profit jumped 21.7% to Rs 162.49 crore on a 14.1% rise in net sales to Rs 963.49 crore in Q3 FY25 over Q3 FY24.

Shares of JB Chemicals & Pharmaceuticals rose 0.88% to end at Rs 1,518 on Thursday, 13 March 2025.